Abstract
A 28-year-old woman without any history of prior antituberculosis treatment presented with cervical lymphadenopathy and a cold abscess near medial end of clavicle of 5 months duration. Pus culture and sensitivity revealed Mycobacterium tuberculosis resistant to rifampicin and isoniazid. Thus she was diagnosed as a case of primary multidrug-resistant tuberculosis and treated with second line drugs according to culture susceptibility pattern. On completion of therapy, patent showed good clinical response. This case highlights the observation that even extra-pulmonary primary multidrug-resistant tuberculosis can be successfully treated with currently available second line drugs.
MeSH terms
-
Adult
-
Antitubercular Agents / therapeutic use*
-
Clarithromycin / therapeutic use
-
Clofazimine / therapeutic use
-
Cycloserine / therapeutic use
-
Diagnosis, Differential
-
Drug Therapy, Combination
-
Ethambutol / therapeutic use
-
Ethionamide / therapeutic use
-
Female
-
HIV Seronegativity
-
Humans
-
Isoniazid / therapeutic use
-
Kanamycin / therapeutic use
-
Ofloxacin / therapeutic use
-
Pyrazinamide / therapeutic use
-
Rifampin / therapeutic use
-
Tuberculosis, Lymph Node / diagnosis*
-
Tuberculosis, Lymph Node / drug therapy*
-
Tuberculosis, Multidrug-Resistant / diagnosis*
-
Tuberculosis, Multidrug-Resistant / drug therapy*
Substances
-
Antitubercular Agents
-
Pyrazinamide
-
Kanamycin
-
Ethambutol
-
Cycloserine
-
Ofloxacin
-
Clofazimine
-
Clarithromycin
-
Ethionamide
-
Isoniazid
-
Rifampin